Vibrio cholerae

MICROBIOLOGY

  • Facultatively anaerobic, oxidase-positive, curved/comma-shaped Gram-negative bacillus.
    • Cary-Blair transport medium is recommended for stool specimens.
    • Selective thiosulfate–citrate–bile salts-sucrose agar (TCBS, Fig. 1) for culture facilitates organism isolation.
  • Human infection follows ingestion of fecally contaminated water or food; raw or undercooked seafood may also transmit infection.
    • V. cholerae persists naturally in freshwater, brackish, estuarine, and coastal aquatic environments.
    • Toxigenic strains cause epidemics and are reported as cholera.
      • Cholera toxin activates adenylate cyclase in small-intestinal enterocytes, increasing intracellular cAMP and CFTR-mediated chloride secretion while inhibiting sodium absorption, resulting in massive electrolyte and water loss without mucosal invasion or significant inflammation.
      • Toxigenic V. cholerae O1 and O139 strains can cause cholera.
        • O1 El Tor lineage organisms account for the ongoing seventh pandemic and all recent outbreaks.
        • Classical O1 strains have largely disappeared from circulation.
        • O139 emerged in India and Bangladesh in 1992 and caused outbreaks in Asia, but is now detected only sporadically.
      • Reagents for serotyping isolates are available through state health departments in the U.S.
        • Send all isolates to the CDC via state health department labs for subtyping and cholera toxin testing.
      • Aquatic environments are an important natural reservoir.
        • V. cholerae can persist in association with plankton, copepods, shellfish, and chitinous surfaces.
      • Antimicrobial susceptibility varies substantially by geography and outbreak and may also evolve over time.
        • Treatment should be informed by contemporary local susceptibility data whenever available.
    • Non-O1/non-O139 V. cholerae (NOVC)
      • NOVC strains are usually nontoxigenic and cause vibriosis rather than epidemic cholera.
      • They can cause gastroenteritis and, less commonly, invasive infections such as wound infection and bacteremia, particularly in patients with cirrhosis or other immunocompromising conditions.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: October 11, 2026